Frazier Life Sciences XI, L.P. — SEC Form 4 filings

SEC reporting owner CIK 1911592. 1 Form 4 filing on record with FilingPulse; latest filed 2026-08-06.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2026-08-06 to 2026-08-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Attovia Therapeutics, Inc. (ATTO)10% owner11 leg · 588,235 sh · $9,999,9958

Form 4 filings — Frazier Life Sciences XI, L.P.

FiledFormIssuerReported transactionsSource
2026-08-064Attovia Therapeutics, Inc. (ATTO)
jointly with FHMLS XI, L.P., FHMLS XI, L.L.C.
Conversion (C): 1,749,192 · Conversion (C): 1,590,175 · Conversion (C): 1,189,940 · Conversion (C): 961,322 · Purchase (P): 588,235 @ $17 · Conversion (C): 16,250,000 (derivative) @ $0 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1911592 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →